Atopic Dermatitis Clinical Trials

Do you have eczema? You may be a candidate for our Clinical Research Study! Medical Center for Clinical Research is currently seeking eligible applicants for a clinical research study for an investigational topical lotion.

This study is a 2-part (parts A and B) phase 2/3 study to evaluate the safety, pharmacokinetics (PK) and efficacy of dupilumab in patients 6 months to less than 6 years of age with severe atopic dermatitis (AD).

The main objective of the trial is to demonstrate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) in participants ≥6 years to <12 years of age with severe atopic dermatitis (AD). The secondary objective is to assess the safety of dupilumab administered concomitantly with TCS in patients ≥6 ...

Do you or a loved one have eczema (also called "atopic dermatitis")? If so, you might be interested in a clinical study now enrolling. Wake Research is testing a study drug for eczema and we need people to take part.  

This study will be testing an investigational medication for Atopic Dermatitis

This study will be testing an investigational medication for the treatment of atopic dermatitis

Chronic itch associated with Prurigo Nodularis

Unhappy with your options for eczema? Considering different options? Wake Research is enrolling volunteers in a study of the efficacy, safety and tolerability of an investigational ointment for mild to moderate eczema, also called atopic dermatitis. Your participation in the study could last up to three months. You’ll receive study-related ...

The purpose of the trial is to test if the trial drug, tralokinumab, is better than placebo or ‘dummy treatment’ at treating moderate to severe atopic dermatitis. This will be judged by a range of assessments that rate the severity and extent of atopic dermatitis, itch and several other symptoms, ...

The main purpose of this study is to compare the safety, efficacy, and tolerability of a once-daily topical application of IDP-123 Lotion compared to the IDP-123 Vehicle Lotion in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-123 ...